Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$49,844,246
-$14,767,054 QoQ
Shares Held
165,579
-15.2% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#81
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ALNY ranks #4 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,844,246 | 165,579 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $64,611,300 | 195,277 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $77,647,524 | 195,266 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $89,602,632 | 196,497 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $65,376,153 | 200,485 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $48,998,639 | 181,463 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $42,256,499 | 179,578 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $49,898,142 | 181,428 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $42,118,461 | 173,327 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $25,957,821 | 173,689 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $33,089,620 | 172,873 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $30,473,774 | 172,071 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $33,302,939 | 175,334 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $31,629,526 | 157,895 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $35,266,309 | 148,396 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,358,869 | 136,685 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $18,743,329 | 128,511 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $18,921,555 | 115,877 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $20,321,110 | 119,832 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $21,922,540 | 116,109 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $19,734,670 | 116,415 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $17,228,427 | 122,023 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $16,450,562 | 126,572 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $19,495,548 | 133,898 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $20,805,752 | 140,475 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $12,188,696 | 111,977 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||